Published in Clin Exp Immunol on February 01, 2002
Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res Ther (2006) 1.13
Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res Ther (2005) 1.07
Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach. Arthritis Res Ther (2011) 0.90
Molecular characterization of virus-induced autoantibody responses. J Exp Med (2004) 0.80
Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update. Rambam Maimonides Med J (2016) 0.75
[New biomarkers for large vessel vasculitis and spondyloarthropathies]. Z Rheumatol (2017) 0.75
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (1990) 6.23
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06
Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A (1995) 4.89
Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med (1982) 3.30
Serological identification of human tumor antigens. Curr Opin Immunol (1997) 1.91
Search for varicella zoster virus in giant cell arteritis. Ann Neurol (1998) 1.78
Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci U S A (1998) 1.68
Kinetic trapping of oxygen in cell respiration. Nature (1996) 1.04
Recent progress in the understanding of B-cell functions in autoimmunity. Scand J Immunol (2001) 1.01
Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum (2000) 0.96
Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma (1999) 0.96
The expression of nuclear lamins in human liver: an immunohistochemical study. Hum Pathol (1993) 0.93
Large vessel vasculitides. Curr Opin Rheumatol (1998) 0.87
Acute hepatitis caused by alverine associated with anti-lamin A and C autoantibodies. J Hepatol (1997) 0.87
NA14 is a novel nuclear autoantigen with a coiled-coil domain. J Biol Chem (1998) 0.86
Methylation of satellite DNA. Biochem Biophys Res Commun (1983) 0.83
Autoantibodies in hepatitis delta. Biomed Pharmacother (1995) 0.83
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 6.67
Cooperation and competition in the evolution of ATP-producing pathways. Science (2001) 6.04
Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A (1995) 4.89
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Treatment of older patients with mantle-cell lymphoma. N Engl J Med (2012) 3.46
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
METATOOL: for studying metabolic networks. Bioinformatics (1999) 2.97
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia (2012) 2.78
Metabolic pathway analysis: basic concepts and scientific applications in the post-genomic era. Biotechnol Prog (1999) 2.66
Pathway alignment: application to the comparative analysis of glycolytic enzymes. Biochem J (1999) 2.40
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res (2000) 2.09
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol (2012) 2.03
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res (1996) 1.93
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A (1998) 1.92
Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today (1997) 1.91
Serological identification of human tumor antigens. Curr Opin Immunol (1997) 1.91
Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer (1998) 1.82
Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci U S A (1998) 1.68
Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology (1998) 1.65
EB/RP gene family encodes tubulin binding proteins. Int J Cancer (1999) 1.63
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines. Clin Cancer Res (2001) 1.62
SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer (1997) 1.60
Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. J Clin Oncol (1995) 1.58
Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's disease. Digestion (2010) 1.45
Ulnar deviation is not always rheumatoid. Ann Rheum Dis (1996) 1.41
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy. Ann Oncol (1999) 1.40
Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.40
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv (1999) 1.39
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.38
Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet (1997) 1.37
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol (2010) 1.35
Processing of artificial visual feedback in the walking fruit fly Drosophila melanogaster. J Exp Biol (1997) 1.33
Molecular beacons for DNA biosensors with micrometer to submicrometer dimensions. Anal Biochem (2000) 1.28
Mathematical analysis of enzymic reaction systems using optimization principles. Eur J Biochem (1991) 1.28
Expression of cancer testis genes in human brain tumors. Clin Cancer Res (2000) 1.25
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer (1998) 1.25
Expression of SSX genes in human tumors. Int J Cancer (1998) 1.24
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia. Leukemia (2012) 1.23
Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem (1997) 1.21
The modelling of metabolic systems. Structure, control and optimality. Biosystems (1998) 1.20
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol (1994) 1.18
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood (1996) 1.17
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. Ann Oncol (2010) 1.17
Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg (1994) 1.15
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma. Ann Oncol (2007) 1.14
Analysis of structural robustness of metabolic networks. Syst Biol (Stevenage) (2004) 1.13
Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease. Cancer Res (1990) 1.13
Refined algorithm and computer program for calculating all non-negative fluxes admissible in steady states of biochemical reaction systems with or without some flux rates fixed. Comput Appl Biosci (1993) 1.10
[Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas]. Dtsch Med Wochenschr (1995) 1.07
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia. Ann Oncol (2011) 1.07
RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells. J Immunol (1997) 1.06
The B lymphocyte in rheumatoid arthritis: analysis of rearranged V kappa genes from B cells infiltrating the synovial membrane. Eur J Immunol (1995) 1.05
Detection of central pulmonary artery thromboemboli by transesophageal echocardiography in patients with severe pulmonary embolism. J Am Soc Echocardiogr (1992) 1.03
Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg (1996) 1.00
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. Science (1994) 0.99
Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Sternberg cells. Int J Cancer (1994) 0.99
Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells. Eur J Cancer (1996) 0.98
Lung growth and airway function after lobectomy in infancy for congenital lobar emphysema. J Clin Invest (1980) 0.98
Regulatory O2 tensions for the synthesis of fermentation products in Escherichia coli and relation to aerobic respiration. Arch Microbiol (1997) 0.98
Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions. Br J Cancer (1994) 0.97
Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody. Blood (1997) 0.97
Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor. J Biol Response Mod (1988) 0.97
Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications. Cancer Surv (1985) 0.97
Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma (1999) 0.96
Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma. Leuk Lymphoma (1994) 0.95
[Monolayer cultures of pancreatic tissue. II. Formation of histotypic aggregates from cell suspensions of fetal human pancreas]. Z Zellforsch Mikrosk Anat (1970) 0.94
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Ann Oncol (2009) 0.94
Bronchial artery embolization in cystic fibrosis; technique and long-term results. J Pediatr (1979) 0.93
The B lymphocyte in rheumatoid arthritis: recirculation of B lymphocytes between different joints and blood. Autoimmunity (1999) 0.93
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone. J Clin Oncol (2001) 0.93
Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement. Ann Hematol (2001) 0.92
Evidence for a selected humoral immune response encoded by VH4 family genes in the synovial membrane of a patient with rheumatoid arthritis (RA). Clin Exp Immunol (1996) 0.92
Exploring metabolic pathways in genome-scale networks via generating flux modes. Bioinformatics (2010) 0.92
The insulin-like growth factors in adipogenesis and obesity. Endocrinol Metab Clin North Am (2012) 0.91
Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev (2000) 0.91
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol (1998) 0.91
A bispecific diabody that mediates natural killer cell cytotoxicity against xenotransplantated human Hodgkin's tumors. Blood (1999) 0.91
Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br J Haematol (1998) 0.91
Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. Ann Oncol (1991) 0.90
How to recognize monofunctional units in a metabolic system. J Theor Biol (1996) 0.89
Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis. Neurosci Lett (1998) 0.89
Defining control coefficients in non-ideal metabolic pathways. Biophys Chem (1995) 0.89
Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell lines. Int J Cancer (1997) 0.89
Game theoretical modelling of survival strategies of Candida albicans inside macrophages. J Theor Biol (2010) 0.89
A theoretical approach to the evolution and structural design of enzymatic networks: linear enzymatic chains, branched pathways and glycolysis of erythrocytes. Bull Math Biol (1987) 0.88
Enrichment polymerase chain reaction for the detection of Ki-ras mutations: relevance of Taq polymerase error rate, initial DNA copy number, and reaction conditions on the emergence of false-positive mutant bands. J Cancer Res Clin Oncol (1999) 0.87
Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann Thorac Surg (1999) 0.87
Control analysis of metabolic systems involving quasi-equilibrium reactions. Biochim Biophys Acta (1998) 0.87
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma. Genes Immun (2007) 0.87
Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease. Ann Oncol (1994) 0.87
Hodgkin and Reed-Sternberg cells do not carry T-cell receptor gamma gene rearrangements: evidence from single-cell polymerase chain reaction examination. Blood (1995) 0.86
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody. Cancer Res (1990) 0.86
A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo. Int J Cancer (1993) 0.86
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group. Ann Oncol (1997) 0.86
Modeling the interrelations between the calcium oscillations and ER membrane potential oscillations. Biophys Chem (1997) 0.86